메뉴 건너뛰기




Volumn 35, Issue 1, 2010, Pages 40-41

Pancreatic neuroendocrine tumor with involvement of the inferior mesenteric vein diagnosed by Ga-68 DOTA-TATE PET/CT

Author keywords

Ga 68 DOTA TATE PET CT; Inferior mesenteric vein; Neuroendocrine tumor; Pancreas; Tumor thrombus

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; 68GA DOTATATE; 68GA-DOTATATE; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT;

EID: 75149152486     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181c3b74a     Document Type: Article
Times cited : (19)

References (8)
  • 1
    • 24044471816 scopus 로고    scopus 로고
    • Pancreatic neuroendocrine tumor with portal vein tumor thrombus: PET demonstration
    • Nguyen BD. Pancreatic neuroendocrine tumor with portal vein tumor thrombus: PET demonstration. Clin Nucl Med. 2005;30:628-629.
    • (2005) Clin Nucl Med , vol.30 , pp. 628-629
    • Nguyen, B.D.1
  • 2
    • 75149194820 scopus 로고    scopus 로고
    • PET and PET/CT imaging of neuroendocrine tumors
    • Wahl RL, ed. Philadelphia, PA: Lippincott Williams and Wilkins
    • Baum RP, Prasad V. PET and PET/CT imaging of neuroendocrine tumors. In: Wahl RL, ed. Principles and Practice of PET and PET/CT. Philadelphia, PA: Lippincott Williams and Wilkins; 2009:411-437.
    • (2009) Principles and Practice of PET and PET/CT , pp. 411-437
    • Baum, R.P.1    Prasad, V.2
  • 3
    • 34250349188 scopus 로고    scopus 로고
    • Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
    • Antunes P, Ginj M, Zhang H, et al.. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging. 2007;34:982-993.
    • (2007) Eur J Nucl Med Mol Imaging , vol.34 , pp. 982-993
    • Antunes, P.1    Ginj, M.2    Zhang, H.3
  • 4
    • 34547877609 scopus 로고    scopus 로고
    • Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view
    • Prasad V, Fetscher S, Baum RP. Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view. J Pharm Pharmaceut Sci. 2007;10:321s-337s.
    • (2007) J Pharm Pharmaceut Sci , vol.10
    • Prasad, V.1    Fetscher, S.2    Baum, R.P.3
  • 5
    • 40549112349 scopus 로고    scopus 로고
    • Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma
    • Sun L, Guan YS, Pan WM, et al.. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol. 2008;28:1212-1217.
    • (2008) World J Gastroenterol , vol.28 , pp. 1212-1217
    • Sun, L.1    Guan, Y.S.2    Pan, W.M.3
  • 6
    • 37349114413 scopus 로고    scopus 로고
    • FDG-PET/CT in oncology German Guideline
    • Krause BJ, Beyer T, Bockisch A, et al.. FDG-PET/CT in oncology German Guideline. Nuklearmedizin. 2007;46:291-301.
    • (2007) Nuklearmedizin , vol.46 , pp. 291-301
    • Krause, B.J.1    Beyer, T.2    Bockisch, A.3
  • 8
    • 3042698685 scopus 로고    scopus 로고
    • Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: A preliminary report
    • Miceli M, Atoui R, Walker R, et al.. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. Clin Oncol. 2004;22: 1949-1956.
    • (2004) Clin Oncol , vol.22 , pp. 1949-1956
    • Miceli, M.1    Atoui, R.2    Walker, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.